SECsense Logo

Y-MABS Therapeutics, Inc. 8-K Report: Key Updates for January 6, 2025

$YMAB
Form 8-K
Filed on: 2025-01-10
Source
Y-MABS Therapeutics, Inc. 8-K Report: Key Updates for January 6, 2025

Based on the provided XML section from the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Y-MABS Therapeutics, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK Number: 0001722964
  • IRS Number: 47-4619612
  • Address: 230 Park Avenue, Suite 3350, New York, NY 10169
  • Phone Number: 646-885-8505
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: January 6, 2025
  • SEC File Number: 001-38650
  1. Stock Information:
  • Common Stock Par Value: $0.0001
  • Ticker Symbol: YMAB
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Duration: The report covers a single day, from January 6, 2025, to January 6, 2025.

Summary:

Y-MABS Therapeutics, Inc. filed an 8-K report with the SEC on January 6, 2025. The report pertains to the company's operations and developments as of the filing date. The company is incorporated in Delaware and trades on NASDAQ under the ticker symbol YMAB. The common stock has a par value of $0.0001.